BIOMAT Database Logo BIOMAT Database Logo

Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes. 1990

J Szebeni, and S M Wahl, and G V Betageri, and L M Wahl, and S Gartner, and M Popovic, and R J Parker, and C D Black, and J N Weinstein
Theoretical Immunology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

The antiviral effects of 2',3'-dideoxycytidine (ddC), 2',3'-dideoxycytidine-5'-triphosphate (ddCTP) and liposome-encapsulated ddCTP [L(ddCTP)] were compared in cultured human monocyte-macrophages (M/M) infected with HIV-1. These treatments inhibited virus replication at nanomolar drug levels with activities in the order ddC greater than ddCTP = L(ddCTP). Studies on drug stability and uptake suggest that a large part of the free ddCTP is dephosphorylated before entering the cells, whereas L(ddCTP) remains stable over days and is taken up, probably by endocytosis. The response to L(ddCTP) suggests that the capability of liposomes for targeting drugs to macrophages in vivo could potentially be exploited to improve the therapeutic index of dideoxynucleoside drugs.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003845 Deoxycytosine Nucleotides Cytosine nucleotides which contain deoxyribose as the sugar moiety. Deoxycytidine Phosphates,Nucleotides, Deoxycytosine,Phosphates, Deoxycytidine

Related Publications

J Szebeni, and S M Wahl, and G V Betageri, and L M Wahl, and S Gartner, and M Popovic, and R J Parker, and C D Black, and J N Weinstein
Inhibition of vesicular stomatitis virus RNA synthesis by 2',3'-dideoxycytidine 5'-triphosphate.
March 1983, The Journal of general virology,
J Szebeni, and S M Wahl, and G V Betageri, and L M Wahl, and S Gartner, and M Popovic, and R J Parker, and C D Black, and J N Weinstein
Inhibition of murine retrovirus-induced immunodeficiency disease by dideoxycytidine and dideoxycytidine 5'-triphosphate.
November 1993, Journal of acquired immune deficiency syndromes,
J Szebeni, and S M Wahl, and G V Betageri, and L M Wahl, and S Gartner, and M Popovic, and R J Parker, and C D Black, and J N Weinstein
Effects of 2',3'-dideoxycytidine and 2',3'-dideoxycytidine 5'-triphosphate on phospholipid metabolism in permeabilized rat hepatocytes.
September 1997, Biochemical pharmacology,
J Szebeni, and S M Wahl, and G V Betageri, and L M Wahl, and S Gartner, and M Popovic, and R J Parker, and C D Black, and J N Weinstein
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate.
April 1999, International journal of pharmaceutics,
J Szebeni, and S M Wahl, and G V Betageri, and L M Wahl, and S Gartner, and M Popovic, and R J Parker, and C D Black, and J N Weinstein
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate.
June 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
J Szebeni, and S M Wahl, and G V Betageri, and L M Wahl, and S Gartner, and M Popovic, and R J Parker, and C D Black, and J N Weinstein
FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine 5'-triphosphate.
May 1995, Veterinary immunology and immunopathology,
J Szebeni, and S M Wahl, and G V Betageri, and L M Wahl, and S Gartner, and M Popovic, and R J Parker, and C D Black, and J N Weinstein
Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
January 1993, Drug metabolism and disposition: the biological fate of chemicals,
J Szebeni, and S M Wahl, and G V Betageri, and L M Wahl, and S Gartner, and M Popovic, and R J Parker, and C D Black, and J N Weinstein
Specific inhibition of DNA biosynthesis induced by 3'-amino-2',3'-dideoxycytidine.
November 1988, Biochemistry,
J Szebeni, and S M Wahl, and G V Betageri, and L M Wahl, and S Gartner, and M Popovic, and R J Parker, and C D Black, and J N Weinstein
Inhibition of macrophage mediated cytotoxicity by exogenous adenosine 5'-triphosphate.
December 1984, Journal of clinical & laboratory immunology,
J Szebeni, and S M Wahl, and G V Betageri, and L M Wahl, and S Gartner, and M Popovic, and R J Parker, and C D Black, and J N Weinstein
[HIV infection. Zidovudine and 2',3'-dideoxycytidine in AIDS].
December 1988, Medizinische Monatsschrift fur Pharmazeuten,
Copied contents to your clipboard!